2021 Outstanding Achievement in Clinical Diabetes Research Award
Hans-Henrik Parving, MD, DMSc
Hans-Henrik Parving, MD, DMSc, is the recipient of the 2021 Outstanding Achievement in Clinical Diabetes Research Award. This award recognizes exceptional contributions in patient-oriented clinical outcomes research that have had a significant impact on diabetes prevention and treatment.
Currently professor and chief physician in the Department of Endocrinology, National Hospital, University of Copenhagen, Denmark, Dr. Parving has focused his research on diabetic micro- and macroangiopathy since 1975.
Early in his career, Dr. Parving demonstrated the importance of early intensive antihypertensive treatment in diabetic nephropathy and the importance of microalbuminuria as a risk marker for development of diabetic kidney disease. His lab evaluated using ACE and non–ACE inhibitors to prevent and treat diabetic nephropathy in type 1 patients. In the Steno Type 2 study, Dr. Parving showed that intensified multifactorial intervention delays the progression of microvascular and macrovascular complications, including heart failure and stroke, and improves the prognosis in high-risk patients with type 2 diabetes and microalbuminuria. The Parving lab documented that angiotensin II receptor antagonists help prevent diabetic nephropathy and protect against end stage renal disease in type 2 diabetes.
Dr. Parving has published more than 650 peer-reviewed papers and 100 reviews and text-book chapters, and 21 research fellows from Parving’s lab have defended their doctoral theses. In 2005, Dr. Parving was knighted by Queen Margrethe II of Denmark.
Please join us in celebrating Hans-Henrik Parving, MD, DMSc, for remarkable contributions that have substantially influenced the clinical care of diabetes.